Issuance of the revised interim DR process comes on the heels of a Request for Comments issued by the USPTO on July 20, 2022 seeking stakeholders’ feedback on the current interim DR process, including ...
In a bulletin issued July 24, 2022, focused on Director Review of Patent Trial and Appeal Board (PTAB) decisions in AIA trials, the USPTO also announced the creation of “a new Appeals Review Panel ...
Section 1071 of the Lanham Act provides parties two options for appealing adverse ex parte decisions from the Trademark Trial and Appeal Board (TTAB). The dissatisfied party may either appeal to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback